Drawing for BRAEBURN BYYOURSIDE

USPTO serial 98023513

BRAEBURN BYYOURSIDE

Reviewed by CopyMark Law Group

Status 734Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
DELANEY, ZHALEH SYBIL
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 734: Status 734 means the fifth and typically final extension to file a Statement of Use was granted. You must file an acceptable Statement of Use before this last extension expires or the application will abandon.

Need help with BRAEBURN BYYOURSIDE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,246*

Plus Government fees of $600

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sara M. Bauer

Sara M. Bauer Womble Bond Dickinson (US) LLP470 Atlantic Avenue, Suite 600Independence WharfBoston, MA 02110

Goods and services

ClassDescriptionStatusFirst use
009Downloadable software in the nature of a mobile application for transmitting health and wellness information; downloadable software in the nature of a mobile application for authorising access to databases featuring health and wellness information; none of the forgoing related to the field of end of life counseling, child birth or doula servicesACTIVE—
041Educational services, namely, conducting programs, workshops, seminars and conferences in the fields of health and wellness; educational services, namely, conducting programs, workshops, seminars and conferences in the fields of chemical addiction and its treatment and opioid dependence and its treatment; none of the forgoing related to the field of end of life counseling, child birth or doula servicesACTIVE—
042Providing temporary use of online non-downloadable chatbot software for replying to questions from medical patients regarding obtaining prior authorizations for medical appointments and treatments, and for transmitting information to medical patients in the form of on-line website links to patient chemical addiction and opioid dependence assistance programs; providing temporary use of web-based software applications for operating and authorizing access to an internet website portal for users to participate in discussions regarding medical treatments; computer services, namely, creating an online community for registered users to participate in discussions and get and provide feedback from or to others regarding medical treatments; providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports in the field of addiction treatment; providing medical research information in the field of pharmaceuticals; providing scientific research information in the field of pharmaceuticals; providing medical research information in the field of pharmaceuticals to patients; providing scientific research information in the field of pharmaceuticals to patients; none of the forgoing related to the field of end of life counseling, child birth or doula servicesACTIVE—
044Providing health and medical information to patients; providing personalized healthcare and medical information to patients; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals to patients; providing addiction treatment information in the field of opioid addictions to patients; providing medical information in the field of opioid dependence and its treatment to patients; providing addiction treatment information in the fields of chemical and opioid addictions; providing medical information and advice in the fields of chemical addiction and its treatment and opioid dependence and its treatment; providing health care information and medical advice; providing pharmaceutical advice; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing medical information to healthcare providers and patients about medication, medical symptoms, and medication administration; charitable services, namely, patient assistance program to provide pharmaceuticals free of charge to disadvantaged or low-income patients without prescription drug coverage; medical services; medical consultations; providing a website featuring medical information about medical conditions and treatments therefor; none of the forgoing related to the field of end of life counseling, child birth or doula servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 27, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 27, 2026EX5GSOU EXTENSION 5 GRANTED—
Oct 21, 2026EXT5SOU EXTENSION 5 FILED—
Oct 21, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 18, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 17, 2026EX4GSOU EXTENSION 4 GRANTED—
Jun 17, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 22, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 22, 2025EX3GSOU EXTENSION 3 GRANTED—
Dec 17, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 16, 2025EXT4SOU EXTENSION 4 FILED—
Dec 16, 2025EXT3SOU EXTENSION 3 FILED—
Jul 9, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 8, 2025EX2GSOU EXTENSION 2 GRANTED—
Jun 18, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 17, 2025EXT2SOU EXTENSION 2 FILED—
Jun 11, 2025EX1GSOU EXTENSION 1 GRANTED—
Jun 11, 2025DPCCDIVISIONAL PROCESSING COMPLETE—
Feb 19, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 5, 2024DRRRDIVISIONAL REQUEST RECEIVED—
Dec 5, 2024ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Dec 5, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 5, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 4, 2024EXT1SOU EXTENSION 1 FILED—
Jun 18, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 23, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 23, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 3, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 13, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 28, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Feb 28, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 28, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 28, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 23, 2024DOCKASSIGNED TO EXAMINER—
Oct 3, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 3, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 3, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 3, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 3, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 6, 2023MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 5, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 5, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance